|
|
EQSNews: SCHOTT Pharma AG & Co. KGaA
/ Key words: Forecast/Preliminary Results
SCHOTT Pharma confirms outlook for FY 24 based on Q2 results; FY 25 impacted by slower growth from syringes
14.05.2024 / 18:19 CET/CEST
The issuer is solely responsible for the content of this announcement.
SCHOTT Ph... Lire le communiqué |
|
| |
|
| |
|
|
EQSAdhoc: SCHOTT Pharma AG & Co. KGaA / Key words: Forecast
SCHOTT Pharma AG & Co. KGaA: SCHOTT Pharma see FY 25 impacted by slower growth from syringes
14May2024 / 18:03 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation EU No 596/2014, transmitted by EQS News a service of EQS Group AG.
The issuer is solely respon... Lire le communiqué |
|
| |
|
| |
|
|
EQSNews: SCHOTT Pharma AG & Co. KGaA
/ Key words: Personnel
SCHOTT Pharma appoints Tobias Erfurth as Head of Investor Relations
30.04.2024 / 17:00 CET/CEST
The issuer is solely responsible for the content of this announcement.
SCHOTT Pharma appoints Tobias Erfurth as Head of Investor Relations... Lire le communiqué |
|
| |
|
| |
|
|
EQSNews: SCHOTT Pharma AG & Co. KGaA
/ Key words: Strategic Company Decision/Expansion
SCHOTT Pharma to Expand in the U.S. with New Prefillable Syringe Manufacturing Facility
18.03.2024 / 18:40 CET/CEST
The issuer is solely responsible for the content of this announcement.
SCHOTT Pharma to Expand... Lire le communiqué |
|
| |
|
| |
|
|
EQSNews: SCHOTT Pharma AG & Co. KGaA
/ Key words: AGM/EGM
Successful 2024 Annual General Meeting of SCHOTT Pharma: Shareholders approve all items on the agenda
14.03.2024 / 16:26 CET/CEST
The issuer is solely responsible for the content of this announcement.
Successful 2024 Annual General Meeti... Lire le communiqué |
|
| |
|
| |
|
|
EQSNews: SCHOTT Pharma AG & Co. KGaA
/ Key words: Quarterly / Interim Statement/Quarter Results
SCHOTT Pharma reports good start into fiscal year 2024
29.02.2024 / 07:00 CET/CEST
The issuer is solely responsible for the content of this announcement.
SCHOTT Pharma reports good start into fiscal... Lire le communiqué |
|
| |
|
| |
|
|
EQSNews: SCHOTT Pharma AG & Co. KGaA
/ Key words: Annual Report/Forecast
SCHOTT Pharma delivers on 2023 targets and continues profitable growth trajectory
26.01.2024 / 07:00 CET/CEST
The issuer is solely responsible for the content of this announcement.
SCHOTT Pharma delivers on 2023 targets an... Lire le communiqué |
|
| |
|
| |
